Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dexketoprofen + thiamine + pyridoxine + cyanocobalamin is a **fixed-dose combination drug** consisting of a nonsteroidal anti-inflammatory drug (NSAID)—**dexketoprofen**—and three B-vitamins: **thiamine** (B1), **pyridoxine** (B6), and **cyanocobalamin** (B12). It is developed for the treatment of **acute pain in musculoskeletal disorders**, particularly grade I–II cervical sprains[1][3][5]. Dexketoprofen acts mainly as a **COX inhibitor**, providing analgesic and anti-inflammatory effects. The B vitamins contribute additional analgesic activity, believed to work through multiple mechanisms, such as **modulation of neurotransmitter synthesis**, **antioxidant and anti-inflammatory pathways**, **activation of adenosine receptors**, **modulation of voltage-gated sodium channels** (thiamine), and **GABAergic/serotonergic activity** (pyridoxine, cyanocobalamin)[5]. This combination has demonstrated **superior efficacy and better safety profile** in reducing pain intensity and adverse events compared to dexketoprofen monotherapy in phase IIIb trials for cervical sprain pain[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dexketoprofen + thiamine + pyridoxine + cyanocobalamin.